- Home
- PRGO vs WRBY Comparison
PRGO vs WRBY Comparison
Compare PRGO & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- WRBY
- Stock Information
- Founded
- PRGO 1887
- WRBY 2010
- Country
- PRGO Ireland
- WRBY United States
- Employees
- PRGO N/A
- WRBY N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- WRBY Ophthalmic Goods
- Sector
- PRGO Health Care
- WRBY Health Care
- Exchange
- PRGO Nasdaq
- WRBY Nasdaq
- Market Cap
- PRGO 3.3B
- WRBY 3.1B
- IPO Year
- PRGO 1991
- WRBY 2021
- Fundamental
- Price
- PRGO $25.34
- WRBY $24.07
- Analyst Decision
- PRGO Buy
- WRBY Buy
- Analyst Count
- PRGO 4
- WRBY 12
- Target Price
- PRGO $35.00
- WRBY $22.25
- AVG Volume (30 Days)
- PRGO 1.1M
- WRBY 1.2M
- Earning Date
- PRGO 02-27-2025
- WRBY 02-27-2025
- Dividend Yield
- PRGO 4.36%
- WRBY N/A
- EPS Growth
- PRGO N/A
- WRBY N/A
- EPS
- PRGO N/A
- WRBY N/A
- Revenue
- PRGO $4,392,000,000.00
- WRBY $742,527,000.00
- Revenue This Year
- PRGO N/A
- WRBY $16.92
- Revenue Next Year
- PRGO $4.56
- WRBY $13.42
- P/E Ratio
- PRGO N/A
- WRBY N/A
- Revenue Growth
- PRGO N/A
- WRBY 13.47
- 52 Week Low
- PRGO $23.14
- WRBY $11.35
- 52 Week High
- PRGO $33.46
- WRBY $28.68
- Technical
- Relative Strength Index (RSI)
- PRGO 56.23
- WRBY 38.22
- Support Level
- PRGO $23.86
- WRBY $24.64
- Resistance Level
- PRGO $24.89
- WRBY $26.08
- Average True Range (ATR)
- PRGO 0.57
- WRBY 1.13
- MACD
- PRGO 0.11
- WRBY -0.32
- Stochastic Oscillator
- PRGO 86.55
- WRBY 9.72
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About WRBY Warby Parker Inc.
Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.